+検索条件
-Structure paper
タイトル | 35B5 antibody potently neutralizes SARS-CoV-2 Omicron by disrupting the N-glycan switch via a conserved spike epitope. |
---|---|
ジャーナル・号・ページ | Cell Host Microbe, Vol. 30, Issue 6, Page 887-895.e4, Year 2022 |
掲載日 | 2022年6月8日 |
![]() | Xiaofei Wang / Xiangyu Chen / Jiaxing Tan / Shuai Yue / Runhong Zhou / Yan Xu / Yao Lin / Yang Yang / Yan Zhou / Kai Deng / Zhiwei Chen / Lilin Ye / Yongqun Zhu / ![]() |
PubMed 要旨 | The SARS-CoV-2 Omicron variant harbors more than 30 mutations in the spike protein, leading to immune evasion from many therapeutic neutralizing antibodies. We reveal that a receptor-binding domain ...The SARS-CoV-2 Omicron variant harbors more than 30 mutations in the spike protein, leading to immune evasion from many therapeutic neutralizing antibodies. We reveal that a receptor-binding domain (RBD)-targeting monoclonal antibody, 35B5, exhibits potent neutralizing efficacy to Omicron. Cryo-electron microscopy structures of the extracellular domain trimer of Omicron spike with 35B5 Fab reveal that Omicron spike exhibits tight trimeric packing and high thermostability, as well as significant antigenic shifts and structural changes, within the RBD, N-terminal domain (NTD), and subdomains 1 and 2. However, these changes do not affect targeting of the invariant 35B5 epitope. 35B5 potently neutralizes SARS-CoV-2 Omicron and other variants by causing significant conformational changes within a conserved N-glycan switch that controls the transition of RBD from the "down" state to the "up" state, which allows recognition of the host entry receptor ACE2. This mode of action and potent neutralizing capacity of 35B5 indicate its potential therapeutic application for SARS-CoV-2. |
![]() | ![]() ![]() ![]() |
手法 | EM (単粒子) |
解像度 | 2.98 - 3.4 Å |
構造データ | EMDB-32594, PDB-7wly: EMDB-32595, PDB-7wlz: |
化合物 | ![]() ChemComp-NAG: |
由来 |
|
![]() | VIRAL PROTEIN / IMMUNE SYSTEM |